Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.13

-0.59

-0.04

0.5

Details

Expected EPS

-0.802911

Actual EPS

0.5

Surprise EPS

1.3

Surprise Percent

+162.27%

Description

Cartesian Therapeutics (RNAC) has reported earnings of 0.5 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.